A detailed history of Rb Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rb Capital Management, LLC holds 13,184 shares of PFE stock, worth $352,276. This represents 0.1% of its overall portfolio holdings.

Number of Shares
13,184
Previous 13,276 0.69%
Holding current value
$352,276
Previous $368,000 -0.0%
% of portfolio
0.1%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $2,323 - $2,723
-92 Reduced 0.69%
13,184 $368,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $123,081 - $141,336
4,754 Added 55.79%
13,276 $368,000
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $73,764 - $95,812
-2,823 Reduced 24.88%
8,522 $245,000
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $4,620 - $5,401
144 Added 1.29%
11,345 $376,000
Q2 2023

Dec 11, 2023

SELL
$36.12 - $41.79 $5,201 - $6,017
-144 Reduced 1.27%
11,201 $410,000
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $77,477 - $89,639
2,145 Added 23.69%
11,201 $410,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $25,603 - $33,332
650 Added 7.73%
9,056 $369,000
Q4 2022

Jan 10, 2023

BUY
$41.75 - $54.5 $6,930 - $9,047
166 Added 2.01%
8,406 $431,000
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $80,912 - $98,773
1,849 Added 28.93%
8,240 $361,000
Q2 2022

Jul 14, 2022

BUY
$46.53 - $55.17 $43,970 - $52,135
945 Added 17.35%
6,391 $335,000
Q1 2022

Apr 11, 2022

BUY
$45.75 - $56.69 $15,600 - $19,331
341 Added 6.68%
5,446 $282,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $10,577 - $15,680
-256 Reduced 4.78%
5,105 $301,000
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $36,070 - $46,335
-919 Reduced 14.63%
5,361 $231,000
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $718 - $813
-20 Reduced 0.32%
6,280 $246,000
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $13,228 - $14,919
-395 Reduced 5.9%
6,300 $228,000
Q4 2020

Feb 04, 2021

BUY
$33.47 - $42.56 $7,597 - $9,661
227 Added 3.51%
6,695 $246,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $205,359 - $240,933
6,468 New
6,468 $238,000
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $225,056 - $273,026
-7,472 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $201,968 - $288,568
7,472 New
7,472 $246,000
Q3 2019

Oct 10, 2019

SELL
$32.49 - $42.13 $152,118 - $197,252
-4,682 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $173,140 - $194,396
4,682 New
4,682 $203,000
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $194,789 - $236,268
-5,651 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $18,369 - $19,584
-557 Reduced 8.97%
5,651 $205,000
Q1 2018

Apr 19, 2018

SELL
$31.91 - $37.02 $15,699 - $18,213
-492 Reduced 7.34%
6,208 $220,000
Q4 2017

Feb 05, 2018

SELL
$33.26 - $35.29 $498 - $529
-15 Reduced 0.22%
6,700 $243,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $208,165 - $229,317
6,715
6,715 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rb Capital Management, LLC Portfolio

Follow Rb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.